The latest announcement is out from VECTOR Inc. ( (JP:6058) ).
Pharmaceutical Technology on MSN
Alternative commercialisation models offer lifeline to future of gene therapies
Nonprofit founder and CEO, Craig Martin, notes that the industry will likely see more alternative gene therapy commercialisation models in the future.
Fast Lane Only on MSN
Why the Vector W8 was madness nobody was ready for
The Vector W8 arrived as if it had slipped through a wormhole from a stranger, faster future, a low, angular projectile that ...
GPUs, born to push pixels, evolved into the engine of the deep learning revolution and now sit at the center of the AI ...
Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...
AMD Phase 3 timing, Otsuka funding to 2028, and mixed 4D-710 data with financial risk. See why FDMT stock is a hold.
Uber remains too cheap given its growth, profitability, and potential TAM. Click here to find out why UBER stock is a Strong ...
Faced with dwindling gas supplies, manufacturers are shutting down, but more than 2000 homes were hooked up this year.
Nonlinear dendritic integration in single presubicular neurons provides a mechanism for combining vestibular-based head-direction signals and visual landmark signals to anchor the brain’s internal ...
WEST PALM BEACH, FL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (the “Company”), announces Chief Executive Officer Seamus Lagan has provided the following Year-End Review to ...
Approximately $1.71 billion in H1 2025 losses came from compromised wallets, compared to roughly $410 million from classic phishing attacks. Attackers don't need to "break" blockchains when they can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results